▪︎US President Donald Trump/ White House photo

US President Donald Trump has signed an executive order kick-starting the process of pulling out the United States from the World Health Organisation (WHO).

The US is the largest funder of the WHO and in 2023 contributed almost one-fifth of the agency’s budget.

The exit means the US will leave the WHO in 12 months and cease all financial contributions to the organisation’s work.

The order was one of many issued by Trump after his second coming as US president on Monday.

At the signing of the order, Trump said “World Health ripped us off, everybody rips off the United States. It’s not going to happen anymore”.

This is the second time Trump has ordered that the US pulls out of the WHO.

In 2020, during Trump’s first term as president, he was critical of how the WHO tackled the COVID-19 pandemic, and accused the organisation of being biased towards China in how it issued guidance.

Lagos State is poised to launch an aggressive Polio Outbreak Response across all 20 Local Governments and Local Council Development Areas to uphold the nation’s polio-free status.

This comprehensive Outbreak Response (OBR) will take place from Saturday, January 18, to Tuesday, January 22, 2025.

Dr. Abimbola Bowale, the Supervising Permanent Secretary of the Lagos State Primary Health Care Board, announced this initiative during a press briefing at Alausa, Ikeja.

She emphasized that the entire country remains at risk of wild poliovirus reinfection, particularly following recent outbreaks of wild poliovirus type 1 in Malawi and Mozambique.

In addition, she highlighted the commencement of the Lagos State Government’s integrated Measles and Yellow Fever vaccination campaign, which began on October 19, 2024.

This Integrated Supplemental Immunization Activities (SIA) campaign serves as a significant public health initiative aimed at closing gaps in immunization coverage and controlling the spread of vaccine-preventable diseases within Lagos State.

“Our mission is clear: the health and safety of Lagosians is our top priority,” stated Dr. Bowale.

“To maintain our hard-earned polio-free status, the Lagos State Government, in collaboration with the National Primary Health Care Development Agency, will implement this Polio Outbreak Response across all LGAs and LCDAs.”

She firmly noted that this campaign is essential to “avert any potential setbacks to our significant accomplishments. If left unchecked, the virus poses a serious threat, and we must take decisive action to ensure the integrity of the country’s polio-free status.”

The Nigeria Centre for Disease Control and Prevention (NCDC) has issued the following Public Health Advisory  on Human Metapneumovirus (HMPV) Awareness, Preparedness, and Prevention.

The document released by, Dr. Jide Idris, the Director – GeneralNigeria Centre for Disease Control and Prevention, said :

” NCDC is committed to safeguarding the health of all Nigerians. In response to recent reports of increased Human Metapneumovirus (HMPV) activity in China and other affected regions, as well as growing public interest in the matter, the NCDC in collaboration with the Federal Ministry of Health and Social Welfare is closely monitoring global developments.

We aim to provide timely, accurate information and guidance to keep the Nigerian public informed and prepared. Global situation update.

It is important to note that the rumor circulating about the World Health Organization (WHO) declaring HMPV a Public Health Emergency of International Concern (PHEIC) is false and should be disregarded.

The WHO has not made such a declaration. Recent reports indicate a significant rise in Human Metapneumovirus (HMPV) cases in China, as well as increased respiratory infections linked to HMPV in countries such as the United Kingdom (UK), France, and Germany, particularly during the winter season.

The UK Health Security Agency (UKHSA) has highlighted a notable rise in hospital admissions due to HMPV-related complications, especially among children under five and older adults in care homes.

This trend emphasizes the need for heightened preparedness and vigilance.  

Current Situation in Nigeria

Nigeria operates a National Influenza Sentinel Surveillance (NISS) system, comprising sentinel sites distributed across the six geopolitical zones of the country.

These sites, which include tertiary and secondary health facilities, monitor Influenza-like Illness (ILI) and Severe Acute Respiratory Infections (SARI).

As of January 6, 2025, data from this surveillance system does not indicate any unusual increase in respiratory infections, including those caused by Human Metapneumovirus (HMPV).

However, given the global trends in HMPV cases, the Nigeria Centre for Disease Control and Prevention (NCDC) is proactively implementing measures to strengthen the country’s preparedness and response capacity.

NCDC Preparedness Measures

The NCDC is closely monitoring the situation and has implemented the following actions to ensure public health safety:

1.     Dynamic Risk Assessment

On January 6, 2025, the Nigeria Centre for Disease Control and Prevention (NCDC), in collaboration with the Federal Ministry of Health and partners such as the World Health Organization (WHO), the U.S. Centers for Disease Control and Prevention (USCDC), and the UK Health Security Agency (UKHSA), conducted a dynamic risk assessment for Human Metapneumovirus (HMPV).

The assessment classified the risk of HMPV for Nigeria as moderate.

This evaluation will inform and guide preparedness efforts, decision-making, and response strategies to mitigate potential impacts.

  2.     Public Health Advisory:

Issued this advisory to provide Nigerians with up-to-date information on preparedness actions and preventive measures.

  3.     Point of Entry (POE):

The Nigeria Centre for Disease Control and Prevention (NCDC), in collaboration with Port Health Authorities, is taking proactive steps to ensure robust preparedness at all international points of entry (PoEs) in response to the dynamic risk assessment for Human Metapneumovirus (HMPV).

These measures are designed to mitigate the potential risk of HMPV transmission through international travel. Key actions include  

▪︎   Conducting a comprehensive situation analysis at all international PoEs to assess current readiness levels.

▪︎   An Entry Implementation Protocol on HMPV, approved by the Honourable Minister of Health and Social Welfare, is being developed and will be distributed to all points of entry to guide response activities.

▪︎  In addition, quarantine facilities are being identified and prepared to manage any suspected or confirmed cases if required.

▪︎  Infection Prevention and Control (IPC) materials are being deployed to PoEs to ensure adherence to hygiene and safety protocols.

▪︎  Information, Education, and Communication (IEC) materials are being developed and distributed to raise awareness and provide clear guidelines for frontline staff and travelers at PoEs.

4.     Enhanced Surveillance and Laboratory Diagnosis:

The National Influenza Sentinel Surveillance (NISS) sites across the six geopolitical zones monitor Influenza-like Illness (ILI) and Severe Acute Respiratory Infections (SARI).

This platform, which is already testing for COVID-19, will now also start testing for HMPV. Provisions will be made to increase the number of tests conducted.

Additionally, laboratories in states with international airports will be supported to enable them to test for HMPV.

5.     Infection Prevention and Control (IPC):

Advisories have been issued to hospitals nationwide on enhanced IPC practices, including proper hand hygiene, environmental cleaning, respiratory hygiene, and cough etiquette.

All health facilities are required to identify an appropriate isolation room where cases can be quickly isolated while receiving care.

6.     Case Management Preparedness:

Collaborating with state governments and healthcare facilities to provide training for healthcare workers to ensure adequate case management teams are in place and ready to respond if needed.

This will ensure that healthcare workers are able to provide appropriate care and maintain a high index of suspicion. Supportive care and an emphasis on a high index of suspicion are crucial.

We are requesting state governments to activate their treatment centers or isolation centers to ensure they are prepared to manage cases appropriately.

7.  Stockpiling of Medical Countermeasures:

Relevant materials such as PPEs (face masks, hand gloves, hand hygiene supplies, and other essential IPC items) have been stockpiled for rapid deployment if required.

Additionally, laboratory consumables, reagents, and other necessary supplies have also been stockpiled to ensure readiness.

Risk Communication and Community Engagement:Engaging with the public through clear and accurate messages to address concerns, dispel misinformation, and encourage appropriate health-seeking behaviors.

We work in close collaboration with state risk communication and community engagement pillars, health educators, and other trusted voices, such as the media.

These efforts reflect NCDC’s commitment to proactive coordination and response at all levels of public health.  

Public Advisory What is HMPV?

Human Metapneumovirus (HMPV) is a respiratory virus that can cause illnesses ranging from mild cold-like symptoms to severe respiratory infections, particularly in:

• Young children •

Older adults

• Individuals with weakened immune systems

There is no specific antiviral treatment or vaccine for HMPV.

Supportive care, such as rest, hydration, and fever management, remains the primary approach to recovery.

Symptoms

• Cough

• Fever

• Nasal congestion

• Shortness of breath

• Wheezing

• Bronchitis or pneumonia (in vulnerable populations such as very young children, older people, patients with low immunity such and those on cancer treatment, uncontrolled diabetes etc).

The incubation period is 3-5 days after exposure, and infections typically resolve within 2-5 days with supportive care.

We urge the public to adhere to the preventive measures outlined above and to seek medical attention if experiencing symptoms consistent with HMPV infection.

However, high-risk populations may experience complications.

Transmission HMPV spreads through:

• Respiratory droplets from coughing and sneezing

• Close personal contact (e.g., touching or shaking hands)

• Touching contaminated surfaces and then touching the face.

Overcrowding and poor ventilation can lead to increased transmission, e.g., in congregate settings such as correctional centers and poorly managed IDPs.

Preventive Measures

To reduce the risk of HMPV infection, the public is advised to follow these preventive steps:

For the General Public:

• Hand Hygiene: Wash hands frequently with soap and water for at least 20 seconds.

• Respiratory Etiquette: Cover your mouth and nose with a tissue or elbow when coughing or sneezing. Cover your mouth an nose with face mask if you are experiencing flu like symptoms.

• Avoid Close Contact: Maintain distance from individuals showing symptoms of respiratory illness.

• Avoid overcrowded places.

• Disinfect Surfaces: Regularly clean and disinfect frequently touched objects and surfaces.

• Self-Isolation: Stay home if experiencing symptoms to prevent spreading the virus. As is correct parctice and seek medical care from appropriate sources.

Protecting Vulnerable Groups:

• Young children, older adults, and individuals with underlying health conditions such as people with chronic diseases such as diabetes, on cancer treatment, immunicompromised paients or those with low immunity should seek prompt medical attention if experiencing severe symptoms.   Healthcare Guidance

For Healthcare Workers:

• Reinforce Infection Prevention and Control (IPC) measures in healthcare facilities.

• Enhance surveillance for acute respiratory infections and report unusual increases to the relevant authorities. Index of suspiciona nd enhanced

• Use appropriate PPE when attending to patients with respiratory symptoms.

• Educate patients on preventive measures and when to seek emergency medical care.

• Provide symptomatic care and promptly refer severe cases to specialist facilities.  

Conclusion

The NCDC remains dedicated to protecting the health of Nigerians through continuous surveillance and prompt response to infectious diseases.

We urge the public to adhere to the preventive measures outlined above and to seek medical attention if experiencing symptoms consistent with HMPV infection.

We also emphasize the importance of relying on verified information from the NCDC and WHO.

For emergencies, please contact the NCDC’s toll-free line at 6232 or email us at info@ncdc.gov.ng.

Follow us on our verified social media platforms for timely updates.

Together, we can protect our communities from respiratory infections and ensure a healthier Nigeria.  

Contact Information • Toll-Free Number: 6232 • SMS: *** • WhatsApp: *** • Twitter: @NCDCGov • Facebook: @NCDCgov • Instagram: @NCDCgov